Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply.

Creator(s)

Christopher R. Nitkin, Children's Mercy HospitalFollow
Troy Richardson
Tamorah Lewis

Document Type

Response or Comment

Publication Date

4-1-2023

Identifier

DOI: 10.1001/jamaophthalmol.2023.0009

Journal Title

JAMA Ophthalmol

Volume

141

Issue

4

First Page

408

Last Page

409

MeSH Keywords

Infant, Newborn; Humans; Retinopathy of Prematurity; Hypertension, Pulmonary; Infant, Premature; Angiogenesis Inhibitors; Intercellular Signaling Peptides and Proteins; Intravitreal Injections; Bevacizumab

Keywords

Retinopathy of Prematurity; Pulmonary Hypertension; Angiogenesis Inhibitors; Intercellular Signaling Peptides and Proteins; Intravitreal Injections; Bevacizumab

Recommended Citation

Nitkin CR, Richardson T, Lewis T. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply. JAMA Ophthalmol. 2023;141(4):408-409. doi:10.1001/jamaophthalmol.2023.0009